A
1.56
0.01 (0.65%)
| Previous Close | 1.55 |
| Open | 1.58 |
| Volume | 133,230 |
| Avg. Volume (3M) | 328,267 |
| Market Cap | 94,494,536 |
| Price / Book | 1.25 |
| 52 Weeks Range | |
| Earnings Date | 12 Nov 2025 |
| Diluted EPS (TTM) | -1.94 |
| Total Debt/Equity (MRQ) | 19.15% |
| Current Ratio (MRQ) | 8.02 |
| Operating Cash Flow (TTM) | -102.48 M |
| Levered Free Cash Flow (TTM) | -63.62 M |
| Return on Assets (TTM) | -31.31% |
| Return on Equity (TTM) | -55.68% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Acumen Pharmaceuticals, Inc. | Bearish | Bearish |
AIStockmoo Score
-0.4
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -2.0 |
| Average | -0.38 |
|
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 11.46% |
| % Held by Institutions | 72.24% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Knollwood Investment Advisory, Llc | 30 Sep 2025 | 1,628,510 |
| 52 Weeks Range | ||
| Median | 8.00 (412.82%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| B of A Securities | 18 Nov 2025 | 8.00 (412.82%) | Buy | 1.66 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |